Perceptive LIFE Sciences Master FUND Ltd., 10% Owner at Aldeyra Therapeutics, Inc. (ALDX), bought 141,000 shares at $6.95 ($980K) on 2022-08-05, disclosed to the SEC on 2022-08-09.
Open-market purchase of $980k ALDX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| ACRV | BUY | 2024-04-15 | $20.0M | — | Filing → |
| ALDX | BUY | 2024-04-03 | $3.8M | — | Filing → |
| ALDX | SELL | 2023-10-18 | $5.0M | — | Filing → |